Targeting PI3K/mTOR signaling in cancer

Brooke M. Emerling, Argun Akcakanat

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Abstract

The American Association for Cancer Research (AACR) Special Conference on Targeting PI3K/mTOR Signaling in Cancer was held in San Francisco, California from February 24 to 27, 2011. The meeting was cochaired by Drs. Lewis C. Cantley, David M. Sabatini, and Funda Meric-Bernstam. The main focus of this event was the therapeutic potential of drugs targeting the PI3K/mTOR signaling pathway for the treatment of cancer. This article summarizes the recent discoveries in the field, with particular emphasis on the major themes of the conference.

Original languageEnglish (US)
Pages (from-to)7351-7359
Number of pages9
JournalCancer Research
Volume71
Issue number24
DOIs
StatePublished - Dec 15 2011

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Targeting PI3K/mTOR signaling in cancer'. Together they form a unique fingerprint.

Cite this